| scholarly article | Q13442814 |
| P50 | author | Sten Vermund | Q42891634 |
| Nulda Beyers | Q81746870 | ||
| Helen Ayles | Q42761866 | ||
| Richard J. Hayes | Q38640707 | ||
| P2093 | author name string | Sarah J Fidler | |
| P2860 | cites work | Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial | Q21144715 |
| A review of the effectiveness and acceptability of the female condom for dual protection | Q22248096 | ||
| Combination HIV prevention: significance, challenges, and opportunities | Q22252603 | ||
| Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects | Q24610019 | ||
| Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men | Q24612082 | ||
| Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women | Q24629582 | ||
| Combination prevention: new hope for stopping the epidemic | Q24630559 | ||
| Prevention of HIV-1 infection with early antiretroviral therapy | Q24634688 | ||
| Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review | Q27002617 | ||
| Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus | Q27644501 | ||
| Antiretroviral prophylaxis for HIV prevention in heterosexual men and women | Q28270788 | ||
| Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial | Q29619176 | ||
| Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial | Q29619179 | ||
| Preexposure prophylaxis for HIV infection among African women | Q29620077 | ||
| Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana | Q29620078 | ||
| HIV prevention transformed: the new prevention research agenda | Q30404963 | ||
| Global tuberculosis control: lessons learnt and future prospects | Q30416689 | ||
| Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa | Q33516016 | ||
| Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco | Q33604727 | ||
| Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana | Q33648343 | ||
| Effects of deworming during pregnancy on maternal and perinatal outcomes in Entebbe, Uganda: a randomized controlled trial | Q33803697 | ||
| A research agenda for malaria eradication: health systems and operational research | Q33818057 | ||
| Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials | Q33945929 | ||
| Evaluation of large-scale combination HIV prevention programs: essential issues | Q84414967 | ||
| Demonstration and evaluation of a peer-delivered, individually-tailored, HIV prevention intervention for HIV-infected MSM in their primary care setting | Q85051227 | ||
| Evaluation of impact of long-lasting insecticide-treated bed nets and point-of-use water filters on HIV-1 disease progression in Kenya | Q43353878 | ||
| Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection | Q43575415 | ||
| Assessment of the RTS,S/AS01 malaria vaccine. | Q45785252 | ||
| Effects of home-based voluntary counselling and testing on HIV-related stigma: findings from a cluster-randomized trial in Zambia | Q50105427 | ||
| Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi-site, randomised trial | Q56977949 | ||
| ARVs as HIV Prevention: A Tough Road to Wide Impact | Q59700714 | ||
| Protease inhibitor combination therapy and decreased condom use among gay men | Q77955645 | ||
| Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men | Q77975769 | ||
| Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study | Q79906444 | ||
| Confidential HIV testing and condom promotion in Africa. Impact on HIV and gonorrhea rates | Q39232951 | ||
| Restricted randomization of ZAMSTAR: a 2 x 2 factorial cluster randomized trial | Q39468856 | ||
| HIV/AIDS complacency and HIV infection among young men who have sex with men, and the race-specific influence of underlying HAART beliefs | Q39971883 | ||
| Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users | Q42608007 | ||
| Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis | Q34067511 | ||
| Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa | Q34090912 | ||
| Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study | Q34126545 | ||
| Primary drug resistance in South Africa: data from 10 years of surveys | Q34129300 | ||
| Treatment as prevention--a double hat-trick | Q34201017 | ||
| Can we stop AIDS with antiretroviral-based treatment as prevention? | Q34210416 | ||
| Viral diversity and diversification of major non-structural genes vif, vpr, vpu, tat exon 1 and rev exon 1 during primary HIV-1 subtype C infection | Q34270602 | ||
| Establishing HIV treatment as prevention in the HIV Prevention Trials Network 052 randomized trial: an ethical odyssey | Q34280961 | ||
| Population-level HIV declines and behavioral risk avoidance in Uganda | Q34317500 | ||
| HIV treatment as prevention: the utility and limitations of ecological observation | Q34339533 | ||
| Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? | Q34364357 | ||
| Field comparison of OraQuick ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia | Q34369989 | ||
| Effect of single-dose anthelmintic treatment during pregnancy on an infant's response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial | Q34478860 | ||
| Uptake of home-based voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis | Q34504884 | ||
| Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study | Q34612284 | ||
| High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa | Q34629087 | ||
| Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study | Q34629153 | ||
| Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study | Q34645964 | ||
| Effect of treating co-infections on HIV-1 viral load: a systematic review | Q34767216 | ||
| Compartmental transport model of microbicide delivery by an intravaginal ring | Q34773282 | ||
| Pharmaco-economics of blood transfusion safety: review of the available evidence | Q34803014 | ||
| Interventions to improve the performance of HIV health systems for treatment-as-prevention in sub-Saharan Africa: the experimental evidence | Q34990011 | ||
| Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials. | Q35030752 | ||
| Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study | Q35166201 | ||
| Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial | Q35532840 | ||
| Progress and challenges to male and female condom use in South Africa | Q35776047 | ||
| Effectiveness of condoms in preventing sexually transmitted infections | Q35882388 | ||
| World Health Organization generic protocol to assess drug-resistant HIV among children <18 months of age and newly diagnosed with HIV in resource-limited countries | Q35917564 | ||
| Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy | Q35945325 | ||
| Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study | Q35985936 | ||
| Male circumcision, attitudes to HIV prevention and HIV status: a cross-sectional study in Botswana, Namibia and Swaziland | Q36047841 | ||
| The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double-blind, placebo-controlled trial in Uganda | Q36059796 | ||
| Effects of condom social marketing on condom use in developing countries: a systematic review and meta-analysis, 1990-2010. | Q36160200 | ||
| Statistical considerations for the HPTN 052 Study to evaluate the effectiveness of early versus delayed antiretroviral strategies to prevent the sexual transmission of HIV-1 in serodiscordant couples | Q36309775 | ||
| HIV treatment as prevention and HPTN 052. | Q36364604 | ||
| Vaginal rings for delivery of HIV microbicides. | Q36429890 | ||
| Universal testing and treatment as an HIV prevention strategy: research questions and methods | Q36460647 | ||
| Antiretroviral therapy in prevention of HIV and TB: update on current research efforts | Q36493044 | ||
| Transitioning HIV care and treatment programs in southern Africa to full local management | Q36622806 | ||
| Antiviral agents and HIV prevention: controversies, conflicts, and consensus | Q36836680 | ||
| Lessons learned from HIV-1 vaccine trials: new priorities and directions | Q36839817 | ||
| HIV-1 treatment as prevention: the good, the bad, and the challenges | Q36883784 | ||
| A randomized trial of Mogen clamp versus Plastibell for neonatal male circumcision in Botswana | Q36930520 | ||
| ZAMSTAR, The Zambia South Africa TB and HIV Reduction Study: design of a 2 x 2 factorial community randomized trial | Q36979131 | ||
| Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial | Q37087975 | ||
| Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression | Q37142200 | ||
| Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV | Q37186681 | ||
| Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study | Q37269681 | ||
| Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? | Q37307684 | ||
| Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment | Q37386000 | ||
| Acceptability of male circumcision among adolescent boys and their parents, Botswana | Q37633739 | ||
| Post-exposure prophylaxis for HIV infection | Q37866814 | ||
| Antiretroviral drug resistance--implications for HIV/AIDS reduction in sub-Saharan Africa and other developing countries | Q37869857 | ||
| HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review | Q37923050 | ||
| HIV testing and antiretroviral treatment strategies for prevention of HIV infection: impact on antiretroviral drug resistance. | Q37935116 | ||
| Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review | Q37950537 | ||
| The challenge of malaria eradication in the twenty-first century: research linked to operations is the key. | Q37979411 | ||
| Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs | Q37979471 | ||
| Scaling up interventions to achieve global tuberculosis control: progress and new developments | Q38011369 | ||
| Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries. | Q38014629 | ||
| PEPFAR's evolving HIV prevention approaches for key populations--people who inject drugs, men who have sex with men, and sex workers: progress, challenges, and opportunities | Q38026480 | ||
| "What took you so long?" The impact of PEPFAR on the expansion of HIV testing and counseling services in Africa | Q38026484 | ||
| Progress, challenges, and new opportunities for the prevention of mother-to-child transmission of HIV under the US President's Emergency Plan for AIDS Relief | Q38026485 | ||
| Controlled-release vaginal ring drug-delivery systems: a key strategy for the development of effective HIV microbicides | Q38029677 | ||
| Fifteen million people on antiretroviral treatment by 2015: treatment as prevention | Q38063142 | ||
| Antiretroviral therapy for prevention is a combination strategy | Q38078278 | ||
| Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials | Q38881398 | ||
| HIV drugs for treatment, and for prevention | Q38960007 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prevention of HIV/AIDS | Q7242372 |
| South Africa | Q258 | ||
| Zambia | Q953 | ||
| HIV | Q15787 | ||
| epidemic | Q44512 | ||
| outbreak prevention | Q96043460 | ||
| HIV transmission | Q49029021 | ||
| P304 | page(s) | S221-7 | |
| P577 | publication date | 2013-07-01 | |
| P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
| P1476 | title | Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia | |
| P478 | volume | 63 Suppl 2 |
| Q53404273 | "I was referred from the other side": Gender and HIV testing among older South Africans living with HIV. |
| Q38841512 | "The difference that makes a difference": highlighting the role of variable contexts within an HIV Prevention Community Randomised Trial (HPTN 071/PopART) in 21 study communities in Zambia and South Africa |
| Q37268380 | A composite likelihood approach for estimating HIV prevalence in the presence of spatial variation |
| Q59355882 | Assessing Individual and Disseminated Effects in Network-Randomized Studies |
| Q92658451 | Assessing the feasibility of a life history calendar to measure HIV risk and health in older South Africans |
| Q42561689 | Clinical trials provide the evidence critical for patient empowerment |
| Q38787423 | Consensus statement: Supporting Safer Conception and Pregnancy For Men And Women Living with and Affected by HIV. |
| Q35668867 | Estimated age and gender profile of individuals missed by a home-based HIV testing and counselling campaign in a Botswana community |
| Q33703135 | Global HIV epidemiology: A guide for strategies in prevention and care. |
| Q37280488 | Good Health and Moral Responsibility: Key Concepts Underlying the Interpretation of Treatment as Prevention in South Africa and Zambia Before Rolling Out Universal HIV Testing and Treatment |
| Q30383181 | HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities. |
| Q38734668 | HIV Self-Testing: a Review of Current Implementation and Fidelity |
| Q40851213 | HIV Treatment as Prevention: Implications for Health Promotion |
| Q35164742 | HIV treatment-as-prevention research: authors' reply |
| Q60915581 | HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors |
| Q37483779 | HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model |
| Q35675946 | Implementation of an electronic fingerprint-linked data collection system: a feasibility and acceptability study among Zambian female sex workers |
| Q38452174 | Innovative Strategies for Scale up of Effective Combination HIV Prevention Interventions in Sub-Saharan Africa |
| Q36376230 | Investigating combination HIV prevention: isolated interventions or complex system |
| Q35805339 | Male circumcision and HIV infection among sexually active men in Malawi |
| Q24277713 | Modeling infectious disease dynamics in the complex landscape of global health |
| Q39501636 | Overcoming resistance to HIV testing in sub-Saharan Africa |
| Q35794339 | Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment |
| Q34217032 | Sample size considerations in the design of cluster randomized trials of combination HIV prevention |
| Q56949452 | Shifting the HIV Paradigm from Care to Cure: Proceedings from the Caribbean Expert Summit in Barbados, August 2017 |
| Q44467564 | Test and treat all as soon as possible |
| Q30655512 | The Spear and Shield intervention to increase the availability and acceptability of voluntary medical male circumcision in Zambia: a cluster randomised controlled trial |
| Q56933734 | The impact of a therapeutic exercise intervention on depression and body self-image in HIV-positive women in sub-Saharan Africa |
| Q36380146 | Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa |
| Q37519800 | Who Needs to Be Targeted for HIV Testing and Treatment in KwaZulu-Natal? Results From a Population-Based Survey |
Search more.